Form 8.5 (EPT/RI) - IWG plc   FORM 8.5 (EPT/RI) PUBLIC

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
84
Form 8.5 (EPT/RI) - IWG plc

  FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

1.         KEY INFORMATION

(a) Name of exempt principal trader: 

Investec Bank plc

 
(b) Name of offeror/offeree in relation to whose relevant securities this form relates:
  Use a separate form for each offeror/offeree
 

IWG plc
(c) Name of the party to the offer with which exempt principal trader is connected:

 
 

Investec are Joint Adviser and Joint Broker to IWG plc

 
 d) Date dealing undertaken: 

13th June 2018

 
(e) Has the EPT previously disclosed, or is it today disclosing, in respect of any other party to this offer?No

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a)        Purchases and sales

Class of relevant securityPurchases/ sales

 
Total number of securitiesHighest price per unit paid/received
(pence)

 
Lowest price per unit paid/received
(pence)
 

Ordinary
 Shares

 
 

Purchases
 

621,625
 

313.9
 

312.5
 

Ordinary
 Shares

 
 

Sales
 

621,623
 

313.25
 

312

(b)        Derivatives transactions (other than options)

Class of relevant securityProduct description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securitiesPrice per unit
  

 
   

(c)        Options transactions in respect of existing securities

(i)         Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType
e.g. American, European etc.
Expiry dateOption money paid/ received per unit
        

(ii)        Exercising

Class of relevant securityProduct description
e.g. call option
Number of securitiesExercise price per unit
    

 

(d)        Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing
e.g. subscription, conversion
DetailsPrice per unit (if applicable)
  

 
  

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

3.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
If there are no such agreements, arrangements or understandings, state “none”
 

None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
 

None


  Date of disclosure:

14th June 2018
  Contact name: 

Jacqueline Lovis
  Telephone number: 

0207 597 4815

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Viewbix to Acquire Quantum X Labs for Groundbreaking Innovations

Updated Category News Views 158

Viewbix Enters Agreement to Acquire Quantum X Labs The anticipated acquisition of Quantum X Labs Limited by Viewbix Inc. is set to be a significant move in the field of advanced technology. This strategic acquisition not only reflects Viewbix's commitment to innovation but also highlights its interest in expanding its portfolio in quantum technologies. Understanding the...

Continue Reading
Danaos Corporation Sets First Quarter 2025 Earnings Call Date

Updated Category News Views 226

Danaos Corporation Sets First Quarter 2025 Earnings Call Date Danaos Corporation (NYSE: DAC), a leading independent owner of containerships, has made an exciting announcement regarding its upcoming earnings report. The company will reveal its financial results for the first quarter of 2025, which concludes on March 31, after trading closes. Timing of the Earnings Release...

Continue Reading
Easterly ROCMuni Fund Faces Legal Scrutiny: Investor Alert

Updated Category News Views 179

Investors Under Scrutiny In light of recent developments, investors in the Easterly ROCMuni High Income Municipal Bond Fund should be aware of significant concerns regarding potential securities fraud. Legal inquiries are underway, led by seasoned professionals dedicated to protecting the rights and financial interests of investors. Current Situation An alarming situation...

Continue Reading
ADLINK's Express-PTL Module: Unleashing AI Power with Intel

Updated Category News Views 100

ADLINK Unveils Express-PTL Module with Advanced AI Capabilities ADLINK has introduced its first COM Express module, the Express-PTL, powered by the robust Intel Core Ultra Series 3 processors. This exciting development emphasizes the integration of cutting-edge Intel Arc GPU technology, showcasing a remarkable combination of up to 12 Xe cores and a powerful NPU 5 capable...

Continue Reading
Bridge to Life Secures FDA Approval for Innovative Slush Solution

Updated Category News Views 191

Bridge to Life Announces Major Milestone with FDA Clearance Bridge to Life™ Ltd. has achieved a significant advancement in organ preservation solutions with the announcement of FDA approval for its EasiSlush® Sodium Chloride Solution specifically designed for slush preparation. This innovative product is set to enhance the practices of cardiovascular, abdominal, and...

Continue Reading